BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9689177)

  • 21. Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
    Ekberg M; Hedner U; Larsson I; Nilsson IM; Nosslin B
    Scand J Clin Lab Invest; 1976 Sep; 36(5):453-9. PubMed ID: 790536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation.
    Ekberg M; Bergentz SE; Hedner U; Nilsson IM
    Scand J Urol Nephrol; 1976; 10(1):56-62. PubMed ID: 775625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 24. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
    Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of fibrin (fibrinogen) degradation products in urine].
    Andreenko GV; Podorol'skaia LV
    Lab Delo; 1983; (4):35-8. PubMed ID: 6191081
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fibrin and fibrinogen degradation products (FDP) in renal diseases. II. Serum and urinary FDP in different morphological forms of glomerulonephritis].
    Ratajczak T; Rabczyński J; Szewczyk Z
    Pol Arch Med Wewn; 1978 Apr; 59(4):429-40. PubMed ID: 662758
    [No Abstract]   [Full Text] [Related]  

  • 28. [Letter: Fibrin metabolites in the urine in kidney diseases].
    Arnesen M; Godal HC
    Tidsskr Nor Laegeforen; 1976 Feb; 96(6):396. PubMed ID: 1257987
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary fibrin/fibrinogen derivatives.
    Hedner U
    Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
    Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
    Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen and fibrinogen/fibrin degradation products in the urine of rabbits infected with Trypanosoma (trypanozoon) brucei.
    Boreham PF; Facer CA
    Z Parasitenkd; 1977 Jul; 52(3):257-65. PubMed ID: 906631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
    Sakakibara K; Nagase M; Takada Y; Takada A
    Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B; Srivastava PK; Padmanabhan R; Dube RK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary fibrin and fibrinogen degradation products and the origin of hematuria.
    Tsukahara H; Hiraoka M; Sudo M; Okada T; Morikawa K; Kuroda M
    Acta Paediatr Jpn; 1992 Oct; 34(5):525-9. PubMed ID: 1442024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic difficulties in renal diseases presenting no urinary changes or with minimal abnormalities].
    Chodorowski Z; Muszkowska-Penson J; Stolarczyk J
    Pol Tyg Lek; 1976 Aug; 31(31):1325-7. PubMed ID: 967741
    [No Abstract]   [Full Text] [Related]  

  • 36. [Further observation of the significance of urinary C3 assay in the diagnosis and treatment of glomerular diseases].
    Li LS
    Zhonghua Nei Ke Za Zhi; 1983 Apr; 22(4):219-21. PubMed ID: 6617352
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulation.
    Loschiavo C; Previato G; Valvo E; Lupo A; Tessitore N; Chiaramonte S; Maschio G
    Nephron; 1981; 28(4):200-3. PubMed ID: 7029322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma and urinary fibrin fibrinogen degradation products in a case of renal thromboembolism].
    Massari M; D'Adamo F; Bernardi A; Emma G; Santucci G
    Minerva Urol Nefrol; 1998 Jun; 50(2):155-9. PubMed ID: 9707971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urinary fibrin/fibrinogen degradation products (FDP) in chronic glomerulonephritis].
    Shimamatsu K
    Fukuoka Igaku Zasshi; 1986 Sep; 77(9):480-9. PubMed ID: 3804170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.